Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | Chief Financial Officer | March 28, 2026 | March 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date March 28, 2026 · Filed March 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,818 |
Ending reported balance
After 2026-03-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-28 · Grant · Acquired 4,925 · Balance 46,337 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2026-03-28 · Tax withholding · Disposed 1,519 · Balance 44,818 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-28 · Exercise / conversion · Disposed 4,925 · Balance 0 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 10,290 |
Reported balance
Holding disclosure · report date 2026-03-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 10,290 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Ortho Clinical Diagnostics Holdings plc
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.56 · Expires 2024-10-22 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 398,350 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated December 22, 2021 (the "BCA"), by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). F2: At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Business Combination Agreement, dated December 22, 2021 (the "BCA"), by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time").
F2: At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2026 Filed Mar 31, 2026 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000012 · wk-form4_1774988038.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026. F4 · derivative.expiration_date: 14,775 shares vested in equal installments on March 28, 2024, March 28, 2025 and March 28, 2026. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,519 | $14.78 | $22,450.82 |
DisclosureSEC source: 0001385091-26-000012 · wk-form4_1774988038.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,818 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2026 Filed Mar 31, 2026 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000012 · wk-form4_1774988038.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,337 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 12:44 UTC | QuidelOrtho Corp QDEL · Entity 4986 | PurchaseCommon Stock | 3,370 | $23.66 | $79,741.95 |
DisclosureSEC source: 0001385091-26-000008 · wk-form4_1771004668.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 10,290 Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 16:18 UTC Amendment | QuidelOrtho Corp QDEL · Entity 4986 | PurchaseCommon Stock | 3,370 | $23.66 | $79,741.95 |
DisclosureSEC source: 0001385091-26-000010 · wk-form4a_1771535883.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 10,290 F1 · price: The Form 4 originally filed on February 13, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. The weighted average purchase price of these transactions was $23.6623 per share, with a range of $23.0150 to $23.6750 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000006 · wk-form4_1770757795.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,969 Underlying: Common Stock · 5,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5,968 shares vested on each of February 8, 2025 and February 8, 2026; and the remaining 5,969 shares will vest on February 8, 2027. F4 · derivative.expiration_date: 5,968 shares vested on each of February 8, 2025 and February 8, 2026; and the remaining 5,969 shares will vest on February 8, 2027. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,806 | $29.10 | $52,554.60 |
DisclosureSEC source: 0001385091-26-000006 · wk-form4_1770757795.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,412 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000006 · wk-form4_1770757795.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,218 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 29,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000004 · wk-form4_1770166159.xml · derivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,444 Underlying: Common Stock · 29,444 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation Common Stock. F2 · derivative.exercise_date: 9,814 shares will vest on January 30, 2027; the remaining 19,630 shares will vest in equal installments on January 30, 2028 and January 30, 2029. F2 · derivative.expiration_date: 9,814 shares will vest on January 30, 2027; the remaining 19,630 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000002 · wk-form4_1770077120.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,851 Underlying: Common Stock · 8,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 8,425 shares vested on January 29, 2026; 8,425 shares will vest on January 29, 2027; and the remaining 8,426 shares will vest on January 29, 2028. F4 · derivative.expiration_date: 8,425 shares vested on January 29, 2026; 8,425 shares will vest on January 29, 2027; and the remaining 8,426 shares will vest on January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,602 | $27.41 | $71,320.82 |
DisclosureSEC source: 0001385091-26-000002 · wk-form4_1770077120.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,250 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001385091-26-000002 · wk-form4_1770077120.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,852 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 13:21 UTC | QuidelOrtho Corp QDEL · Entity 4986 | PurchaseCommon Stock | 4,770 | $26.06 | $124,305.25 |
DisclosureSEC source: 0001385091-25-000005 · wk-form4_1764094867.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 6,920 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000140 · wk-form4_1751486927.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,367 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 21,367 shares fully vested on June 30, 2025. F4 · derivative.expiration_date: 21,367 shares fully vested on June 30, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 9,883 | $28.82 | $284,828.06 |
DisclosureSEC source: 0001906324-25-000140 · wk-form4_1751486927.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,427 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000140 · wk-form4_1751486927.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,310 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 16:03 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 5,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000133 · wk-form4_1748981026.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,392 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5,391 shares vested on June 1, 2023, 5,391 shares vested on June 1, 2024, and 5,392 shares vested on June 1, 2025. F4 · derivative.expiration_date: 5,391 shares vested on June 1, 2023, 5,391 shares vested on June 1, 2024, and 5,392 shares vested on June 1, 2025. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 16:03 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,466 | $30.67 | $75,632.22 |
DisclosureSEC source: 0001906324-25-000133 · wk-form4_1748981026.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,943 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 16:03 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 5,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000133 · wk-form4_1748981026.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,409 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000041 · wk-form4_1743538698.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,925 Underlying: Common Stock · 4,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 4,925 shares vested on March 28, 2025; the remaining 4,925 shares will vest on March 28, 2026. F4 · derivative.expiration_date: 4,925 shares vested on March 28, 2025; the remaining 4,925 shares will vest on March 28, 2026. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,602 | $34.89 | $55,893.78 |
DisclosureSEC source: 0001906324-25-000041 · wk-form4_1743538698.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,017 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000041 · wk-form4_1743538698.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,619 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000029 · wk-form4_1739308660.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,937 Underlying: Common Stock · 5,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5, 968 shares vested on February 8, 2025; 5,968 shares will vest on February 8, 2026; and 5,969 shares will vest on February 8, 2027. F4 · derivative.expiration_date: 5, 968 shares vested on February 8, 2025; 5,968 shares will vest on February 8, 2026; and 5,969 shares will vest on February 8, 2027. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,058 | $42.89 | $88,267.62 |
DisclosureSEC source: 0001906324-25-000029 · wk-form4_1739308660.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,694 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000029 · wk-form4_1739308660.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,752 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 18:25 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 25,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000009 · wk-form4_1738365900.xml · derivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,276 Underlying: Common Stock · 25,276 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 16,850 shares will vest in equal installments on January 29, 2026 and January 29, 2027; the remaining 8,426 shares will vest on January 29, 2028. F2 · derivative.expiration_date: 16,850 shares will vest in equal installments on January 29, 2026 and January 29, 2027; the remaining 8,426 shares will vest on January 29, 2028. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 5,391 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068675 · ownership.xml · derivative · entry 4 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,392 Underlying: Common Stock · 5,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5,391 shares vested on June 1, 2024; the remaining 5,392 shares will vest on June 1, 2025. F4 · derivative.expiration_date: 5,391 shares vested on June 1, 2024; the remaining 5,392 shares will vest on June 1, 2025. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,446 | $44.19 | $108,088.74 |
DisclosureSEC source: 0000950170-24-068675 · ownership.xml · nonDerivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,784 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 5,391 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068675 · ownership.xml · nonDerivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,230 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:59 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039666 · ownership.xml · derivative · entry 4 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,850 Underlying: Common Stock · 4,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 4,925 shares vested on March 28, 2024; the remaining 9,850 shares will vest in equal installments on March 28, 2025 and March 28, 2026. F5 · derivative.expiration_date: 4,925 shares vested on March 28, 2024; the remaining 9,850 shares will vest in equal installments on March 28, 2025 and March 28, 2026. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:59 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,234 | $47.94 | $107,097.96 |
DisclosureSEC source: 0000950170-24-039666 · ownership.xml · nonDerivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,839 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:59 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039666 · ownership.xml · nonDerivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,073 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 202 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 17:08 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-023250 · ownership.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 Underlying: Common Stock · 21,367 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 21,367 shares will fully vest on June 30, 2025. F2 · derivative.expiration_date: 21,367 shares will fully vest on June 30, 2025. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 18:48 UTC | QuidelOrtho Corp QDEL · Entity 4986 | PurchaseCommon Stock | 2,150 | $46.36 | $99,663.25 |
DisclosureSEC source: 0000950170-24-020435 · ownership.xml · nonDerivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,150 F1 · price: The weighted average purchase price of these transactions was $46.3550 per share, with a range of $46.3205 to $46.3850 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 17,905 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014152 · ownership.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,905 Underlying: Common Stock · 17,905 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 11,936 shares will vest in equal installments on February 8, 2025 and February 8, 2026; the remaining 5,969 shares will vest on February 8, 2027. F2 · derivative.expiration_date: 11,936 shares will vest in equal installments on February 8, 2025 and February 8, 2026; the remaining 5,969 shares will vest on February 8, 2027. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 5,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034578 · doc4.xml · derivative · entry 3 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,565 Underlying: Common Stock · 5,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 5,391 shares vested on June 1, 2023, 5,391 shares will vest on June 1, 2024 and 5,392 shares will vest on June 1, 2025. F5 · derivative.expiration_date: 5,391 shares vested on June 1, 2023, 5,391 shares will vest on June 1, 2024 and 5,392 shares will vest on June 1, 2025. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,637 | $85.65 | $140,209.05 |
DisclosureSEC source: 0001209191-23-034578 · doc4.xml · nonDerivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,946 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 5,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034578 · doc4.xml · nonDerivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,583 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 192 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021711 · doc4.xml · derivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,775 Underlying: Common Stock · 14,775 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F1 · derivative.exercise_date: 4,925 shares will vest on the first anniversary date of the grant date, March 28, 2024; 4,925 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 4,925 shares will vest on the third anniversary date of the grant date, March 28, 2026. F1 · derivative.expiration_date: 4,925 shares will vest on the first anniversary date of the grant date, March 28, 2024; 4,925 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 4,925 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Option · Derivative | 14,775 | $0.00 Strike: $87.46 | $0.00 |
DisclosureSEC source: 0001209191-23-021711 · doc4.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,775 Underlying: Common Stock · 14,775 shares Expires 2033-03-28 F1 · derivative.exercise_date: 4,925 shares will vest on the first anniversary date of the grant date, March 28, 2024; 4,925 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 4,925 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| January 30, 2023 Filed Jul 1, 2024 20:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Option · Derivative | 21,012 | $0.00 Strike: $119.06 | $0.00 |
DisclosureSEC source: 0000950170-24-079927 · ownership.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,012 Underlying: Common Stock · 21,012 shares Expires 2030-07-07 F1 · derivative.exercise_date: The stock option was originally granted to the Reporting Person on July 7, 2020. Its terms were amended on January 30, 2023 to remove the performance conditions and provide that the stock option would vest in its entirety on December 31, 2023, subject to the Reporting Person's continued service through such date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:13 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 16,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034205 · doc4.xml · derivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,174 Underlying: Common Stock · 16,174 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F3 · derivative.exercise_date: 5,391 shares will vest on 6/1/2023, 5,391 shares will vest on 6/1/2024 and 5,392 shares will vest on 6/1/2025. F3 · derivative.expiration_date: 5,391 shares will vest on 6/1/2023, 5,391 shares will vest on 6/1/2024 and 5,392 shares will vest on 6/1/2025. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:13 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Option · Derivative | 10,411 | $0.00 Strike: $92.74 | $0.00 |
DisclosureSEC source: 0001209191-22-034205 · doc4.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,411 Underlying: Common Stock · 10,411 shares Expires 2032-06-01 F1 · derivative.exercise_date: 3,470 shares will vest on 6/1/2023, 3,470 shares will vest on 6/1/2024 and 3,471 shares will vest on 6/1/2025. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:31 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantStock Options · Derivative | 21,012 | $0.00 Strike: $119.06 | $0.00 |
DisclosureSEC source: 0000899243-22-020481 · doc4.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,012 Underlying: Common Stock · 21,012 shares Expires 2030-07-07 F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement. F2 · derivative.exercise_date: 7,003 shares will vest on July 7, 2022 and 7,006 shares will vest on July 7, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:15 UTC | Ortho Clinical Diagnostics Holdings plc OCDX · Entity 126680 | Disposition to issuerStock Option · Derivative | 398,350 | Not disclosed Strike: $12.56 | Not disclosed |
DisclosureSEC source: 0000899243-22-020384 · doc4.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, $0.00001 par value · 398,350 shares Expires 2024-10-22 F1 · price: Pursuant to the Business Combination Agreement, dated December 22, 2021 (the "BCA"), by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). F2 · price: At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms. F1 · derivative.exercise_date: Pursuant to the Business Combination Agreement, dated December 22, 2021 (the "BCA"), by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). F2 · derivative.exercise_date: At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.